Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype

American Journal of Pathology

Volumn 151, Issue 5, 1997, Pages 1215-1224

  Ortéga, Nathalie ^a   Jonca, Frédéric ^a   Vincent, Sylvie ^b   Favard, Catherine ^c   Ruchoux, Marie Madeleine ^b   Plouët, Jean ^a,d  

^a Université Paul Sabatier   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c HÔTEL DIEU   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; ENDOTHELIUM CELL; GROWTH STIMULATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR UPREGULATION; VASCULAR ENDOTHELIUM;

ADENOCARCINOMA; ANIMALS; CELL DIVISION; CELL MOVEMENT; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPES; INJECTIONS; LIGANDS; LYMPHOKINES; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PROSTATIC NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0344637004     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995, 1:27-31
2. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989, 161:851-856
3. Plouët J, Schilling J, Gospodarowicz D: Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20. EMBO J 1989, 8:3801-3806
4. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder J: Human vascular permeability factor isolation from U937 cells. J Biol Chem 1989, 264:20017-20024
5. Praloran V, Mirshahi S, Favard C, Moukadiri H, Plouët J: Vasculotropin is mitogenic for human peripheral lymphocytes. C R Acad Sci Paris III 1991, 313:21-26
6. Melder RJ, Koenig GC, Witner BP, Safabakhsh N, Munn LL, Jain RK: During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med 1996, 2:992-997
7. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med 1996, 2:1096-1103
8. Guerrin M, Moukadiri H, Chollet P, Moro F, Dull K, Malecaze F, Plouët J: Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells. J Cell Physiol 1995, 164:385-394
9. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992, 255:989-991
10. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Böhlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992, 187:1579-1586
11. Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Moller NPH, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846
12. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT: Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993, 90:7533-7537
13. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442
14. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439
15. Fong G-H, Rossant J, Gertsenstein M, Breitman ML: Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376:66-70
16. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, Breitman ML, Schuh AC: Failure of blood-island formation and vasculogenesis in flk-1 deficient mice. Nature 1995, 376:62-66
17. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, Plouët J: Detection of VEGF mRNA and VEGF like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994, 112:1476-1482
18. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van de Water L, Senger DR: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991, 174:1275-1278
19. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995, 146:1029-1039
20. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362:841-844
21. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant. Nature 1994, 367:576-579
22. Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM: Dominant-negative inhibition of flk-1 suppresses the growth of many tumor types in vivo. Cancer Res 1996, 56:1615-1620
23. Jakeman LB, Winer J, Bennett GL, Altar A, Ferrara N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 1992, 89:244-253
24. Jerne NK, Roland J, Cazenave PA: Recurrent idiotopes and internal images. EMBO J 1982, 1:243-247
25. Sege K, Peterson PA: Use of anti-idiotypic antibodies as cell surface receptor probes. Proc Natl Acad Sci USA 1978, 75:2443-2447
26. Couraud PO, Strosberg AD: Anti-idiotypic antibodies against hormone and neurotransmitter receptors. Biochem Soc Trans 1991, 19: 147-151
27. Fiebich B, Jäger B, Schöllmann C, Weindel K, Wilting J, Kochs G, Marme D, Hug H, Weich HA: Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Eur J Biochem 1993, 211:19-26
28. Plouët J, Moukadiri H: Characterization of the receptor to vasculotropin on bovine adrenal cortex derived capillary endothelial cells. J Biol Chem 1990, 265:22071-22074
29. Gospodarowicz D, Massoglia S, Cheng J, Fujji DK: Effect of fibroblast growth factor and lipoprotein on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex and corpus luteum. J Cell Physiol 1986, 127:121-136
30. Favard C, Moukadiri H, Dorey C, Praloran V, Plouët J: Purification and biological properties of vasculotropin a new angiogenic cytokine. Biol Cell 1991, 73:1-6
31. Gerdes J, Becker MHG, Key G, Cattoretti G: Immunohistological detection of tumor growth fraction (Ki 67 antigen) in formalin fixed and routinely processed tissues. J Pathol 1992, 168:85-86
32. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996, 87:3336-3343
33. Clauss M, Weich H, Breier G, Knies U, Röckl W, Waltenberger J, Risau W: The vascular endothelial growth factor receptor flt-1 mediates biological activities J Biol Chem 1996, 271:17629-17634
34. Simon M, Gröne HJ, Jöhren O, Kullmer J, Plate KH, Risau W, Fuchs E: Expression of vascular endothelial growth factor receptors in human renal ontogenesis and in adult kidney. Am J Physiol 1995, 37:F240-F250
35. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H, Ferrara N: Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors: generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 1996, 271: 5638-5646
36. D'Angelo G, Struman I, Martial J, Weiner RI: Activation of mitogen-activated protein tyrosine kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kd N-terminal fragment of prolactin Proc Natl Acad Sci USA 1995, 92:6374-6378
37. Spaargaren M, Defize LHK, Boonstra J, DeLaa SW: Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase. J Biol Chem 1991, 266:1733-1739
38. Clary DO Weskamp G, Austin LAR, Reichardt LF: TrkA cross-linking mimics neuronal responses to nerve growth factor. Mol Biol Cell 1994, 5:549-563
39. Waltenberger J, Welsh LC, Siegbahn A, Shibuya M, Heldin CH: Different signal transduction properties of KDR and flt-1, two receptors for vascular endothelial growth factor. J Biol Chem 1994, 269: 26988-26995
40. Ortéga N, Dos Santos D, Plouët J: Activation of the VEGF receptor flt-1 mediates corneal endothelial cell migration and permeability. Invest Ophthalmol Vis Sci 1996, 37:S88
41. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993, 143:401-409
42. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967
43. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285:1182-1186
44. Guerrin M, Scottet E, Malecaze F, Houssaint E, Plouët J: Overexpression of vascular endothelial growth factor induces cell transformation in cooperation with fibroblast growth factor 2. Oncogene 1996, 14: 463-471
45. v integrins. Science 1995, 270:1500-1502
46. 165 in patient with ischaemic limb. Lancet 1996, 348:370-374